<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101235741</journal-id>
<journal-id journal-id-type="pubmed-jr-id">32200</journal-id>
<journal-id journal-id-type="nlm-ta">Am J Med Genet A</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Med. Genet. A</journal-id>
<journal-title-group>
<journal-title>American journal of medical genetics. Part A</journal-title>
</journal-title-group>
<issn pub-type="ppub">1552-4825</issn>
<issn pub-type="epub">1552-4833</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28944577</article-id>
<article-id pub-id-type="pmc">6555908</article-id>
<article-id pub-id-type="doi">10.1002/ajmg.a.38492</article-id>
<article-id pub-id-type="manuscript">NIHMS907069</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>De Novo Mutations in <italic>HNRNPU</italic> Result in a Neurodevelopmental Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yates</surname>
<given-names>T Michael</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vasudevan</surname>
<given-names>Pradeep</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chandler</surname>
<given-names>Kate E</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Donnelly</surname>
<given-names>Deirdre E</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stark</surname>
<given-names>Zornitza</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sadedin</surname>
<given-names>Simon</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Willoughby</surname>
<given-names>Josh</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<collab>Broad Center for Mendelian Genomics</collab>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<collab>DDD study</collab>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Balasubramanian</surname>
<given-names>Meena</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Sheffield Clinical Genetics Service, Sheffield Children’s NHS Foundation Trust, Sheffield, UK</aff>
<aff id="A2"><label>2</label>Department of Clinical Genetics, University Hospitals of Leicester, Leicester, UK</aff>
<aff id="A3"><label>3</label>Northern Ireland Regional Genetics Centre, Belfast Health and Social Care Trust/City Hospital, Belfast, Northern Ireland, UK</aff>
<aff id="A4"><label>4</label>Manchester Centre for Genomic Medicine, Saint Mary’s Hospital, Manchester, UK</aff>
<aff id="A5"><label>5</label>Murdoch Children’s Research Institute, Melbourne, Victoria, Australia</aff>
<aff id="A6"><label>6</label>Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA</aff>
<aff id="A7"><label>7</label>Sheffield Diagnostic Genetics Service, Sheffield Children’s NHS Foundation Trust, Sheffield, UK</aff>
<aff id="A8"><label>8</label>Broad Center for Mendelian Genomics, Cambridge, Massachusetts, USA</aff>
<aff id="A9"><label>9</label>DDD Study, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK</aff>
<author-notes>
<corresp id="CR1"><bold>Correspondence:</bold> Dr Meena Balasubramanian, Sheffield Clinical Genetics Service, Sheffield Children’s NHS Foundation Trust, Sheffield, UK, Ph: +44 114 2717025, Fax: +44 114 2737467, <email>meena.balasubramanian@nhs.net</email></corresp>
<fn fn-type="COI-statement" id="FN1">
<p id="P52">CONFLICT OF INTEREST</p>
<p id="P53">The authors do not have any conflict of interest to disclose.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>25</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>25</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>08</day>
<month>6</month>
<year>2019</year>
</pub-date>
<volume>173</volume>
<issue>11</issue>
<fpage>3003</fpage>
<lpage>3012</lpage>
<!--elocation-id from pubmed: 10.1002/ajmg.a.38492-->
<abstract id="ABS1">
<p id="P1">Exome sequencing in the context of developmental disorders is a useful technique, but variants found need to be interpreted in the context of detailed phenotypic information. Whole gene deletions and loss-of-function-mutations in the <italic>HNRNPU</italic> gene have been associated with intellectual disability and seizures in some patients. However, a unifying syndromic phenotype has not been previously elucidated.</p>
<p id="P2">Here, we report a total of seven patients (six patients identified through the Wellcome Trust Deciphering Developmental Disorders study, with one additional patient), who have heterozygous <italic>de novo</italic> mutations in <italic>HNRNPU</italic>. These were found via trio-based exome sequencing. All but one of the mutations is predicted to cause loss-of-function. These patients have dysmorphic features in common, including prominent eyebrows, long palpebral fissures, overhanging columella and thin upper lip. All patients have developmental delay and intellectual disability (ID), ranging from moderate to severe. Seizures are common from early childhood. These initially occur in the context of febrile episodes.</p>
<p id="P3">This series demonstrates common phenotypic features, including emerging dysmorphism, associated with heterozygous <italic>HNRNPU</italic> mutations. This allows us to define a novel neurodevelopmental syndrome, with a likely mechanism of haploinsufficiency.</p>
</abstract>
<kwd-group>
<kwd>
<italic>HNRNPU</italic>
</kwd>
<kwd>seizures</kwd>
<kwd>behaviour</kwd>
<kwd>aggressive outbursts</kwd>
<kwd>trio exome sequencing</kwd>
<kwd>intellectual disability</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>